<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the effect of systemic <z:chebi fb="131" ids="25107">magnesium</z:chebi> on the prevention of postoperative <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> after coronary artery bypass graft surgery </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: A meta-analysis </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Randomized controlled trials evaluating the effect of systemic <z:chebi fb="131" ids="25107">magnesium</z:chebi> on the incidence of postoperative <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>PARTICIPANTS: Patients undergoing coronary artery bypass graft surgery </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTIONS: Systemic perioperative administration of <z:chebi fb="0" ids="32599">magnesium sulfate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: Twenty studies evaluating 3,696 subjects were included </plain></SENT>
<SENT sid="6" pm="."><plain>The combined effect suggested that systemic <z:chebi fb="131" ids="25107">magnesium</z:chebi> reduced the incidence of <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> compared with saline (odds ratio [OR] = 0.69; 95% confidence interval [CI], 0.53-0.90; number needed to treat [NNT] = 14) </plain></SENT>
<SENT sid="7" pm="."><plain>The effect was present for lower-quality studies (Jadad score â‰¤3; OR = 0.47; 95% CI, 0.28-0.81; NNT = 8), but it was not detected for higher-quality studies (Jadad &gt;3; OR = 0.85; 95% CI, 0.66-1.11) </plain></SENT>
<SENT sid="8" pm="."><plain>There was no association between the total dose of <z:chebi fb="131" ids="25107">magnesium</z:chebi> administration and the incidence of <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> (p = 0.19) </plain></SENT>
<SENT sid="9" pm="."><plain>There was no effect of <z:chebi fb="131" ids="25107">magnesium</z:chebi> on the incidence of postoperative <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, <z:chebi fb="131" ids="25107">magnesium</z:chebi> did not reduce the hospital or intensive care unit lengths of stay (<z:hpo ids='HP_0000001'>all</z:hpo> p &gt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The effect of <z:chebi fb="0" ids="32599">magnesium sulfate</z:chebi> in reducing postoperative <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> was significant when examined by lower-quality studies but not when examined by higher-quality studies </plain></SENT>
<SENT sid="12" pm="."><plain>This fact probably is responsible for controversial findings reported in the literature </plain></SENT>
<SENT sid="13" pm="."><plain>Also, <z:chebi fb="0" ids="32599">magnesium sulfate</z:chebi> did not reduce the incidence of complications associated with the development of postoperative <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>More effective strategies should be used to prevent complications caused by <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in this patient population </plain></SENT>
</text></document>